Brian I. Knapp

1.0k total citations
35 papers, 683 citations indexed

About

Brian I. Knapp is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Behavioral Neuroscience. According to data from OpenAlex, Brian I. Knapp has authored 35 papers receiving a total of 683 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 27 papers in Cellular and Molecular Neuroscience and 2 papers in Behavioral Neuroscience. Recurrent topics in Brian I. Knapp's work include Neuropeptides and Animal Physiology (26 papers), Receptor Mechanisms and Signaling (22 papers) and Pharmacological Receptor Mechanisms and Effects (21 papers). Brian I. Knapp is often cited by papers focused on Neuropeptides and Animal Physiology (26 papers), Receptor Mechanisms and Signaling (22 papers) and Pharmacological Receptor Mechanisms and Effects (21 papers). Brian I. Knapp collaborates with scholars based in United States, Italy and Ireland. Brian I. Knapp's co-authors include Jean M. Bidlack, John L. Neumeyer, Xuemei Peng, Ao Zhang, Wennan Xiong, Mark P. Wentland, James E. Hilbert, Michael Decker, Severo Salvadori and Lawrence H. Lazarus and has published in prestigious journals such as Biochemistry, Biological Psychiatry and Pain.

In The Last Decade

Brian I. Knapp

34 papers receiving 675 citations

Peers

Countries citing papers authored by Brian I. Knapp

Since Specialization

Citations

This map shows the geographic impact of Brian I. Knapp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian I. Knapp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian I. Knapp more than expected).

Fields of papers citing papers by Brian I. Knapp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian I. Knapp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian I. Knapp. The network helps show where Brian I. Knapp may publish in the future.

Co-authorship network of co-authors of Brian I. Knapp

This figure shows the co-authorship network connecting the top 25 collaborators of Brian I. Knapp. A scholar is included among the top collaborators of Brian I. Knapp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian I. Knapp. Brian I. Knapp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mu Opioid Receptor Positive Allosteric Modulator BMS-986122 Confers Agonist-Dependent G Protein Subtype Signaling Bias 2025 ·Biochemistry ·(unknown), Brian I. Knapp, Jean M. Bidlack	0
2	Mice with high FGF21 serum levels had a reduced preference for morphine and an attenuated development of acute antinociceptive tolerance and physical dependence 2021 ·Neuropharmacology ·(unknown), Brian I. Knapp, (unknown), (unknown), Jean M. Bidlack	8
3	Unique Pharmacological Properties of the Kappa Opioid Receptor Signaling Through Gαz as Shown with Bioluminescence Resonance Energy Transfer 2020 ·Molecular Pharmacology ·(unknown), Brian I. Knapp, Jean M. Bidlack	7
4	In Vitro Pharmacological Characterization of Buprenorphine, Samidorphan, and Combinations Being Developed as an Adjunctive Treatment of Major Depressive Disorder 2018 ·Journal of Pharmacology and Experimental Therapeutics ·Jean M. Bidlack, Brian I. Knapp, Daniel R. Deaver, (unknown), Derrick R. Arnelle, (unknown), (unknown), Sokhom S. Pin, Mark Namchuk	50
5	Antidepressant-like effects of 3-carboxamido seco-nalmefene (3CS-nalmefene), a novel opioid receptor modulator, in a rat IFN-α-induced depression model 2017 ·Brain Behavior and Immunity ·Charlotte K. Callaghan, (unknown), Reginald L. Dean, Brian I. Knapp, Jean M. Bidlack, Daniel R. Deaver, Shane M. O’Mara	11
6	Preliminary Pharmacological Evaluation of Enantiomeric Morphinans 2014 ·ACS Chemical Neuroscience ·Anna W. Sromek, (unknown), (unknown), Elena H. Chartoff, Brian I. Knapp, Jean M. Bidlack, John L. Neumeyer	17
7	Can Amphipathic Helices Influence the CNS Antinociceptive Activity of Glycopeptides Related to β-Endorphin? 2014 ·Journal of Medicinal Chemistry ·(unknown), (unknown), Brian I. Knapp, M. Dhanasekaran, (unknown), Denise Giuvelis, Jean M. Bidlack, Edward J. Bilsky, Robin Polt	12
8	Synthesis and Pharmacological Evaluation of Aminothiazolomorphinans at the Mu and Kappa Opioid Receptors 2013 ·Journal of Medicinal Chemistry ·(unknown), Anna W. Sromek, Wei Li, (unknown), Elena H. Chartoff, Brian I. Knapp, Jean M. Bidlack, John L. Neumeyer	17
9	Phosphorylation of Enkephalins: NMR and CD Studies in Aqueous and Membrane‐Mimicking Environments 2011 ·Chemical Biology & Drug Design ·Larisa Yeomans, M. Dhanasekaran, John J. Lowery, (unknown), Leif Abrell, (unknown), (unknown), Brian I. Knapp, Jean M. Bidlack, Edward J. Bilsky, Robin Polt	4
10	Brain P450 epoxygenase activity is required for the antinociceptive effects of improgan, a nonopioid analgesic 2011 ·Pain ·Lindsay B. Hough, Julia W. Nalwalk, Jun Yang, Jennie Conroy, (unknown), Weizhu Yang, (unknown), (unknown), (unknown), Mark P. Wentland, James G. Phillips, Brian I. Knapp, Jean M. Bidlack, Obbe P. Zuiderveld, Rob Leurs, Xinxin Ding	12
11	Opioid bifunctional ligands from morphine and the opioid pharmacophore Dmt-Tic 2010 ·European Journal of Medicinal Chemistry ·Gianfranco Balboni, Severo Salvadori, Ewa D. Marczak, Brian I. Knapp, Jean M. Bidlack, Lawrence H. Lazarus, Xuemei Peng, Yu Gui, John L. Neumeyer	10
12	Glycosyl-Enkephalins: Synthesis and Binding at the Mu, Delta & Kappa Opioid Receptors. Antinociception in Mice 2009 ·Advances in experimental medicine and biology ·(unknown), Brian I. Knapp, Jean M. Bidlack, (unknown), Edward J. Bilsky, Robin Polt	3
13	Synthesis and pharmacological evaluation of hydrophobic esters and ethers of butorphanol at opioid receptors 2008 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Brian I. Knapp, Jean M. Bidlack, John L. Neumeyer	8
14	High-affinity carbamate analogues of morphinan at opioid receptors 2007 ·Bioorganic & Medicinal Chemistry Letters ·Xuemei Peng, Brian I. Knapp, Jean M. Bidlack, John L. Neumeyer	10
15	In-vitro investigation of oxazol and urea analogues of morphinan at opioid receptors 2007 ·Bioorganic & Medicinal Chemistry ·Xuemei Peng, Brian I. Knapp, Jean M. Bidlack, John L. Neumeyer	9
16	Glycosylation Improves the Central Effects of DAMGO 2007 ·Chemical Biology & Drug Design ·John J. Lowery, Larisa Yeomans, (unknown), Peg Davis, Frank Porreca, Brian I. Knapp, Jean M. Bidlack, Edward J. Bilsky, Robin Polt	36
17	Synthesis and opioid receptor binding properties of a highly potent 4-hydroxy analogue of naltrexone 2005 ·Bioorganic & Medicinal Chemistry Letters ·Mark P. Wentland, Qun Lu, Rongliang Lou, (unknown), Brian I. Knapp, Jean M. Bidlack	36
18	10-Ketomorphinan and 3-Substituted-3-desoxymorphinan Analogues as Mixed κ and μ Opioid Ligands: Synthesis and Biological Evaluation of Their Binding Affinity at Opioid Receptors 2003 ·Journal of Medicinal Chemistry ·Ao Zhang, Wennan Xiong, Jean M. Bidlack, James E. Hilbert, Brian I. Knapp, Mark P. Wentland, John L. Neumeyer	37
19	Design and Synthesis of Novel Dimeric Morphinan Ligands for κ and μ Opioid Receptors 2003 ·Journal of Medicinal Chemistry ·John L. Neumeyer, Ao Zhang, Wennan Xiong, Xiao‐Hui Gu, James E. Hilbert, Brian I. Knapp, S. Stevens Negus, Nancy K. Mello, Jean M. Bidlack	71
20	ELEMENTS OF GEOGRAPHICAL HYDROLOGY 1979 ·Brian I. Knapp	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact